George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 261.50
Bid: 261.60
Ask: 261.80
Change: 0.80 (0.31%)
Spread: 0.20 (0.076%)
Open: 262.20
High: 262.80
Low: 259.10
Prev. Close: 260.70
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

5 Jul 2022 15:08

RNS Number : 4087R
Marks and Spencer Group PLC
05 July 2022
 

Marks and Spencer Group PLC

AGM Results

 

Marks & Spencer today held its third fully digitally enabled shareholder meeting broadcast from Waterside House, London. At a time when market-wide AGM attendance has been declining, the pioneering format saw M&S shareholder participation increase to 1,687 compared to 1,664 last year. Overall, the digital format has enabled M&S to treble private shareholder engagement levels compared to its last in-person meeting hosted in 2019. A recording of the meeting is available to view on our corporate website here: https://corporate.marksandspencer.com/AGM2022

 

The Board is pleased that all resolutions were carried with substantial support and has noted that the Advisory note on the Directors' Remuneration Report received 70.89% of votes in favour.

 

M&S has been proactively talking to our larger shareholders about this subject and we are aware of the reasons why some shareholders voted against the resolution on the Remuneration Report. However, the Board is convinced that the majority of shareholders were right in their judgement on this issue.

 

The Board strongly believes that it has acted in shareholders' interests and consistent with the values and integrity of the business in relation to Steve Rowe's remuneration. Steve served 37 years with the business, the last six years as Chief Executive Officer. Three weeks prior to the 2022 financial year-end we announced that he would be standing down at the results announcement, as part of a planned succession process that he helped to plan, handing the leadership to a team that he recruited. He worked full time and with total energy as Chief Executive Officer well beyond the end of the financial year.

 

All eligible colleagues have received a bonus this year, the first since 2017, in recognition of the strong financial performance in the year. It would have been wholly wrong to exclude Steve from this as the performance was delivered under his leadership. To have denied him the bonus because he helped support an orderly and organised succession that was announced just three weeks before the year-end would have shown bad faith to a great servant of the business and would not have been in any way in shareholders' interests.

 

Following the AGM the Remuneration Committee intends to engage further with shareholders to understand the concerns expressed by the minority. An update on this engagement will be published in accordance with the UK Corporate Governance Code within six months of today's meeting. In the standard three-year cycle of approval, our Remuneration Policy is due to be reviewed and presented to shareholders at the 2023 AGM.

 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business at an annual general meeting have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Copies of our announcements are available on our website, corporate.marksandspencer.com/investors.

 

 

MARKS AND SPENCER GROUP PLC - AGM - 5 JULY 2022 - POLL RESULT

 

 

 

For (see note 2)

Against (see note 2)

Number of votes Withheld (See note 3)

Total Capital Instructed

Resolution

 

No. of shares

%

No. of shares

%

1

Receive Annual Reports and Accounts

1,339,451,971

99.99

157,191

0.01

1,411,785

68.28%

2

Approve the Remuneration Report

930,901,466

70.89

382,304,226

29.11

27,809,219

68.28%

3

Re-elect Archie Norman

1,288,556,149

96.10

52,271,066

3.90

204,180

68.28%

4

Re-elect Eoin Tonge

1,335,843,323

99.63

4,958,347

0.37

251,353

68.28%

5

Re-elect Evelyn Bourke

1,176,809,541

87.77

163,959,382

12.23

283,901

68.28%

6

Re-elect Fiona Dawson

1,326,480,850

98.93

14,279,272

1.07

290,202

68.28%

7

Re-elect Andrew Fisher

1,316,596,126

98.20

24,159,878

1.80

272,212

68.28%

8

Re-elect Andy Halford

1,305,732,873

97.39

35,035,074

2.61

282,857

68.28%

9

Re-elect Tamara Ingram

1,318,085,555

98.31

22,646,240

1.69

292,311

68.28%

10

Re-elect Justin King

1,326,501,796

98.93

14,310,651

1.07

240,759

68.28%

11

Re-elect Sapna Sood

1,326,415,831

98.93

14,330,957

1.07

277,318

68.28%

12

Elect Stuart Machin

1,340,304,101

99.96

475,033

0.04

267,080

68.28%

13

Elect Katie Bickerstaffe

1,337,195,657

99.73

3,583,671

0.27

269,386

68.28%

14

Re-appoint Deloitte LLP as auditor

1,330,455,419

99.90

1,384,747

0.10

9,206,048

68.28%

15

Authorise Audit Committee to determine auditors' remuneration

1,339,612,877

99.91

1,217,059

0.09

214,229

68.28%

16

Authorise the Company, and its subsidiaries, to make political donations

1,268,497,930

94.75

70,333,790

5.25

2,214,494

68.28%

17

Authorise allotment of ordinary shares

1,313,858,056

97.99

26,945,573

2.01

242,585

68.28%

18

General disapplication pre-emption rights*

1,336,141,058

99.66

4,508,799

0.34

394,992

68.28%

19

Additional disapplication of pre-emption rights*

1,279,181,425

95.41

61,473,173

4.59

390,251

68.28%

20

Authorise purchase of own shares*

1,328,435,544

99.19

10,854,595

0.81

1,755,985

68.28%

21

Call general meetings on 14 days' notice*

1,256,405,720

94.41

74,404,099

5.59

226,395

67.77%

22

Renewal of Share Incentive Plan

1,340,136,466

99.96

543,524

0.04

366,224

68.28%

23

Section 190 transaction

1,340,023,164

99.97

414,688

0.03

606,997

68.28%

* Special Resolution 

NOTES: 1 All resolutions were passed.2 Votes "For" and "Against" are expressed as a percentage of votes received. 3 A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.4 Total number of shares in issue at 6.30pm on 4 July 2022 = 1,964,019,744 shares. 68.28% of voting capital was instructed.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSIFLIEESESW
Date   Source Headline
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSTotal Voting Rights
2nd Jan 20249:00 amRNSBlock listing Interim Review
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:56 pmRNSHolding(s) in Company
6th Jun 202310:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.